menu ☰
menu ˟
Current affairs

Health Well

Peer review on 'Work-capacity assessment and employment of persons with disabilities', Riga, Latvia, 26-27 April 2018

The peer review will be hosted by the Latvian Ministry of Welfare and discuss approaches for assessing and establishing work-capacity or disability, measures to improve labour market integration of persons with disabilities and the role of labour market in ...

Multidimensional poverty in the EU: Social Situation Monitor Seminar

The Social Situation Monitor (SSM) team invites analysts, economists and social researchers to discuss the issue of measuring multidimensional poverty. The seminar will take place in on Monday 12 March 2018 (9am- 5pm) at the ...

Brain signal shows if speech is understood

Irish neuroscientists have identified a specific brain signal that indicates whether speech has been understood. Their discovery could have important potential applications, such as assessing brain function in unresponsive patients, tracking language devel ...

Massacre in Eastern Ghouta must stop now, says EU

The EU has called for an immediate ceasefire and aid deliveries in the rebel-held Syrian enclave of Eastern Ghouta after more than 400 civilians were killed there. ...

Further €1m interim payment for brain-damaged girl

The High Court has approved a further €1m interim payment in the case of an 11-year-old girl who was brain damaged after a failure to diagnose a serious medical condition in her mother in the days before her birth. ...

Axicabtagene ciloleucel CAR T-cell therapy shows long-term benefit for non-Hodgkin lymphoma

Frederick Locke SALT LAKE CITY — The chimeric antigen receptor T-cell therapy axicabtagene ciloleucel induced significant clinical benefit with manageable adverse events among patients with refractory aggressive non-Hodgkin lymphoma, according to long-term ...

Cord blood transplant via NiCord reduces time to neutrophil, platelet recovery

Mitchell E. Horwitz  SALT LAKE CITY — NiCord single unit expanded umbilical cord blood transplantation decreased time to neutrophil and platelet recovery, according to results of a phase 2 study presented at the BMT Tandem Meetings. “Regardless of where th ...

Genetic marker linked to prolonged time on opioids after HSCT

SALT LAKE CITY — Wild-type alleles found in the rs1042713 genotype of the beta-2 adrenergic receptor gene appeared to prolong time to optimal pain control and increase time on scheduled opioids among pediatric patients with mucositis following hematopoieti ...

ILLUMENATE Global: DCB for femoropoliteal lesions safe, effective at 2 years

A drug-coated balloon designed for the treatment of femoropopliteal lesions was safe and effective at 2 years in a real-world cohort, according to results presented at the Leipzig Interventional Course. To assess safety and performance of the DCB (Stellare ...

34% of physicians have been sued: How to best minimize your risk

The AMA released three new trend reports demonstrating the high frequency and cost burden of medical liability claims. “Information in this new research paints a bleak picture of physicians’ experiences with medical liability claims and the associated cost ...

Transplant physicians have ‘substantial concerns’ regarding palliative care services

Areej El-Jawahri, MD, SALT LAKE CITY — Hematopoietic stem cell transplant physicians reported substantial concerns about palliative care clinicians’ knowledge about transplant, according to results of a cross-sectional, web-based survey presented at the BM ...

FDA grants orphan drug designation to GDC-0084 for glioblastoma multiforme

The FDA granted orphan drug designation to GDC-084 for the treatment of patients with glioblastoma multiforme, the most aggressive form of primary brain cancer, according to the agent’s manufacturer. GDC-0084 is a small molecule inhibitor of the PI3K/AKT/m ...

Rebiotix develops metric for microbiome research

Rebiotix announced that it has developed a new metric designed to identify indicators for microbiome restoration, according to a press release. The company developed the Microbiome Health Index (MHI) in a partnership with the data analytics firm BioRanking ...

Diversity in HCV: 10 reports on HCV outcomes by demographic

Although hepatitis C cure rates continue to increase in the direct-acting antiviral era, especially in developed nations, some individuals still fail to achieve sustained virologic responses and others may have more risk factors for infection or transmissi ...

12 European countries commit to greater efforts to protect people from vaccine-preventable diseases

Health ministries of 12 countries in south-eastern Europe and beyond have endorsed a statement of intent to speed up progress towards the goals and strategic objectives of the European Vaccine Action Plan 2015–2020 (EVAP). ...

Extracorporeal photopheresis shows promise for bronchiolitis obliterans syndrome

Mehrdad Hefazi SALT LAKE CITY — Extracorporeal photopheresis stabilized forced expiratory volume in the first breath, or FEV1, values and prolonged survival among patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell tran ...

Trump's Call for Mental Institutions Could Be Good

President Donald Trump continued to point to mental-health solutions to America’s gun-violence problem this week, this time saying that he would like to reopen mental asylums that have been closed over the past few decades. ...

AI-based diabetic retinopathy diagnostic tool achieves FDA trial endpoints

A pivotal FDA trial of an artificial intelligence-based system for the autonomous detection of diabetic retinopathy has met its endpoints, according to a press release from IDx. The IDx-DR system, developed to assess for diabetic retinopathy during routing ...

Social isolation should be a public health priority

Loneliness poses health risks and is a drain on the public purse. Communities are finding ways to connect people, but government must act too The headlines are familiar to many of us: “ Loneliness is as bad for your health as smoking 15 cigarettes a day ” ...

Directly proceeding to HSCT after remission improves ALL outcomes

SALT LAKE CITY — Patients with relapsed or refractory acute lymphoblastic leukemia who achieved complete response to inotuzumab ozogamicin and directly proceeded to hematopoietic stem cell transplantation showed promising OS, according to study results pre ...

IPH Logo

Filter by content type: